Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Antimutagenic" is not a single molecule or receptor but rather a functional property describing agents—both natural and synthetic—that reduce the frequency or impact of mutations caused by mutagens. These agents can act through various mechanisms such as antioxidant activity, inhibition or inactivation of mutagens before they interact with genetic material, enhancement of cellular DNA repair processes, and induction of cell death in mutated cells. Examples include certain vitamins, minerals like selenium and magnesium, carotenoids, flavonoids, and other micronutrients. The term "antimutagenic" is therefore descriptive for a class or function rather than denoting any specific molecular target suitable for structured drug-target databases.
Antioxidant activity (scavenging free radicals and reactive oxygen species); Inhibition of mutagen activation or interaction with DNA; Enhancement of DNA repair pathways (e.g., base excision repair, nucleotide excision repair); Induction of programmed cell death in damaged cells
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Antimutagenic.